Tower Research Capital LLC (Trc) Nkarta, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Nkarta, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,415 shares of NKTX stock, worth $11,169. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,415
Previous 3,019
46.24%
Holding current value
$11,169
Previous $17,000
11.76%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NKTX
# of Institutions
129Shares Held
66.5MCall Options Held
173KPut Options Held
20K-
Ra Capital Management, L.P. Boston, MA10.8MShares$27.3 Million0.68% of portfolio
-
Commodore Capital LP New York, NY4.66MShares$11.8 Million1.79% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$10.3 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA4.03MShares$10.2 Million0.97% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$9.53 Million9.87% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $123M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...